Artivion Inc (NYSE:AORT)
$ 27.73 -1.14 (-3.95%) Market Cap: 1.16 Bil Enterprise Value: 1.52 Bil PE Ratio: 0 PB Ratio: 3.81 GF Score: 77/100

Artivion Inc at UBS Global Healthcare Conference Transcript

May 23, 2022 / 06:45PM GMT
Release Date Price: $18.75 (-0.48%)
Seth Damergy

Thank you, everyone, for joining us for this session. I'm Seth Damergy, I'm a Managing Director in the banking group. And I'm pleased to introduce our next team here. So with us today, we have Artivion. It's a NASDAQ-listed medical device company that's undergone a significant transformation over the past 5 years. And I'm pleased to host this event with Pat Mackin, CEO; and Ashley Lee, CFO of the company, whom I've known for quite some time.

So I'm going to lead in with questions. I think you all know how to ask questions through the device -- the QR code -- and just feel free to send any across.

Questions & Answers

Seth Damergy;James Patrick Mackin
Artivion, Inc. - Chairman,

But I'll start off, Pat and Ashley, with just macro questions to kind of set the stage. I mean, I think we're all hearing about inflation in the news every day. So I thought, at least let's start off with your business. And how do you guys see just inflation in general impacting your business, whether it's through supply chain or whatnot?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot